# Apolipoprotein CIII Reduction Via Colchicine

> **NCT02083510** · EARLY_PHASE1 · COMPLETED · sponsor: **Scripps Translational Science Institute** · enrollment: 5 (actual)

## Conditions studied

- Hypertriglyceridemia
- Gout
- Pericarditis

## Interventions

- **DRUG:** Colchicine

## Key facts

- **NCT ID:** NCT02083510
- **Lead sponsor:** Scripps Translational Science Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2014-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02083510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02083510, "Apolipoprotein CIII Reduction Via Colchicine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02083510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*